The contribution of AR signaling to HCC progression has been supported with abundant clinical and pre-clinical evidence showing its correlation with faster disease progression, tumor burden, disease prognosis, overall survival, and as a mediator of metastasis. Here, AR is linked to hepatocellular carcinoma.